Targeting the Endothelin Axis with Atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma

G. Groenewegen, M. Walraven, J. Vermaat, B. de Gast, E. Witteveen, R. Giles, J. Haanen, E. Voest

Research output: Contribution to journal › Article › Academic › peer-review

65 Downloads (Pure)

Cite this

@article{7f6576e15baa4ed98eed475b83e0cbf1,

title = "Targeting the Endothelin Axis with Atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma",

author = "G. Groenewegen and M. Walraven and J. Vermaat and {de Gast}, B. and E. Witteveen and R. Giles and J. Haanen and E. Voest",

year = "2012",

doi = "10.1038/bjc.2011.515",

language = "Undefined/Unknown",

volume = "106",

pages = "284--289",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Targeting the Endothelin Axis with Atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma

AU - Groenewegen, G.

AU - Walraven, M.

AU - Vermaat, J.

AU - de Gast, B.

AU - Witteveen, E.

AU - Giles, R.

AU - Haanen, J.

AU - Voest, E.

PY - 2012

Y1 - 2012

U2 - 10.1038/bjc.2011.515

DO - 10.1038/bjc.2011.515

M3 - Article

C2 - 22215065

VL - 106

SP - 284

EP - 289

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 2

ER -